Vitreous Cavity Bacterial Contamination and Fluidics After Vitreoretinal Surgery

Overview

About this study

The objective of this study is to evaluate and determine factors such as surgical technique, length of surgery, and surgical instrumentation associated with bacterial contamination of vitreous fluid following vitreoretinal surgery. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients who understand the consent for specimen collection.
Patients who are willing to participate and have already planned vitreoretinal surgery.

Exclusion Criteria:

Patients with endophthalmitis or active inflammation before vitreoretinal surgery.
Those patients unable to understand the consent for specimen collection.
Those patients unwilling to participate.

Eligibility last updated 10/28/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Matthew Starr, M.D.	Open for enrollment	Contact information: Suzanne Wernimont CCRP (507) 538-8119 Wernimont.Suzanne@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Starr, M.D.

Open for enrollment

Contact information:

Suzanne Wernimont CCRP

(507) 538-8119

Wernimont.Suzanne@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials